Cm Management, LLC Cytokinetics Inc Transaction History

Cm Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$32.62 - $40.75 $815,499 - $1.02 Million	-25,000 Reduced 71.43%	10,000 $326,000
Q1 2023 May 08, 2023	SELL	$33.36 - $45.71 $500,400 - $685,650	-15,000 Reduced 30.0%	35,000 $1.23 Million
Q3 2022 Nov 04, 2022	SELL	$38.54 - $54.52 $1.93 Million - $2.73 Million	-50,000 Reduced 50.0%	50,000 $2.42 Million
Q2 2022 Aug 08, 2022	SELL	$33.93 - $48.92 $4.07 Million - $5.87 Million	-120,000 Reduced 54.55%	100,000 $3.93 Million
Q1 2022 May 09, 2022	SELL	$29.74 - $46.0 $1.64 Million - $2.53 Million	-55,000 Reduced 20.0%	220,000 $8.1 Million
Q3 2021 Nov 08, 2021	SELL	$18.54 - $35.74 $927,000 - $1.79 Million	-50,000 Reduced 15.38%	275,000 $9.83 Million
Q4 2020 Feb 04, 2021	BUY	$15.26 - $28.61 $4.96 Million - $9.3 Million	325,000 New	325,000 $6.75 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.